As part of its Community Case Forum series, key opinion leaders and participants discuss the use of CAR T-cell therapy for the treatment of patients with multiple myeloma.
Advancing Multiple Myeloma Treatment With CAR T-Cell Therapy
Daniel Verina, DNP, ACNP-BC, discussed how CAR T-cell therapy is changing the treatment landscape for patients with multiple myeloma.
Understanding the Mechanism of Action Behind PARP Inhibitors for Prostate Cancer
Tools to Monitor for ICANS During Lymphoma Treatment With Bispecific Antibodies, CAR T-Cell Therapy
‘Bringing Every Single Resource’ When Caring for Patients Receiving Treatment for Gynecologic Cancers
Bringing DEI to Clinical Trial, Cancer Clinics Through Self-Awareness